Flk1 Deficiency and Hypoxia Synergistically Promote Endothelial Dysfunction, Vascular Remodeling, and Pulmonary Hypertension
暂无分享,去创建一个
Y. Kubota | M. Ema | M. Ieda | S. Sakai | N. Hizawa | Taketaro Sadahiro | Koji Nakano | Yuto Abe | Yu Yamada | Ryo Fujita | Tatsuya Akiyama | Seiichiro Honda
[1] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.
[2] B. Cockrill,et al. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. , 2022, JAMA.
[3] S. Guttentag,et al. A single-cell atlas of mouse lung development. , 2021, Development.
[4] J. Cortijo,et al. Senescence Alterations in Pulmonary Hypertension , 2021, Cells.
[5] I. Komuro,et al. Three-Dimensional Visualization of Hypoxia-Induced Pulmonary Vascular Remodeling in Mice. , 2021, Circulation.
[6] T. Helbich,et al. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension , 2020, Basic Research in Cardiology.
[7] P. Ainslie,et al. Global Reach 2018 Heightened α-Adrenergic Signaling Impairs Endothelial Function During Chronic Exposure to Hypobaric Hypoxia , 2020, Circulation research.
[8] M. Humbert,et al. Familial pulmonary arterial hypertension by KDR heterozygous loss of function , 2020, European Respiratory Journal.
[9] W. Chung,et al. Bayesian Inference Associates Rare KDR Variants With Specific Phenotypes in Pulmonary Arterial Hypertension , 2019, bioRxiv.
[10] Olga Tanaseichuk,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[11] Denis Torre,et al. BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the Cloud. , 2018, Cell systems.
[12] A. Ntokou,et al. Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension , 2018, Cell reports.
[13] Emma Gordon,et al. Mechanisms and regulation of endothelial VEGF receptor signalling , 2016, Nature Reviews Molecular Cell Biology.
[14] M. Cosio,et al. Destructive index: a measurement of lung parenchymal destruction in smokers. , 2015, The American review of respiratory disease.
[15] Takeshi Miyamoto,et al. Neurons Limit Angiogenesis by Titrating VEGF in Retina , 2014, Cell.
[16] N. Voelkel,et al. The role of vascular endothelial growth factor in pulmonary arterial hypertension. The angiogenesis paradox. , 2014, American journal of respiratory cell and molecular biology.
[17] Satoru Takahashi,et al. Study of normal and pathological blood vessel morphogenesis in Flt1‐tdsRed BAC Tg mice , 2012, Genesis.
[18] Satoru Takahashi,et al. Flk1-GFP BAC Tg mice: an animal model for the study of blood vessel development. , 2010, Experimental animals.
[19] Thomas Colatsky,et al. Biomarkers of Endothelial Cell Activation Serve as Potential Surrogate Markers for Drug-induced Vascular Injury , 2010, Toxicologic pathology.
[20] F. Jaisser,et al. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts , 2010, Transgenic Research.
[21] N. Voelkel,et al. Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension , 2010, Circulation.
[22] A. Barberis,et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis , 2010, Nature.
[23] Allan R. Jones,et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.
[24] P. Escobar,et al. Pulmonary hypertension in two patients treated with bevacizumab for recurrent ovarian cancer. , 2009, Gynecologic oncology.
[25] R. Adams,et al. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. , 2009, Blood.
[26] Zev Rosenwaks,et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. , 2009, Cell stem cell.
[27] Christopher C W Hughes,et al. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. , 2008, Circulation research.
[28] N. Voelkel,et al. Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling. , 2007, American journal of respiratory and critical care medicine.
[29] N. Denis,et al. Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylate , 2007, Oncogene.
[30] N. Voelkel,et al. Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.
[31] M. Brielmeier,et al. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate , 2007, Genesis.
[32] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] N. Voelkel,et al. Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] P. Yue,et al. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. , 2004, Journal of hepatology.
[35] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[36] P. McLoughlin,et al. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation , 2003, The Journal of physiology.
[37] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] S. Eddahibi,et al. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. , 2000, American journal of respiratory cell and molecular biology.
[39] J. Laaban,et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome , 2000, Thorax.
[40] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[41] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[42] B. Groves,et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.
[43] A. Nadas,et al. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. , 1979, The American journal of physiology.
[44] M. Dunnill. Quantitative Methods in the Study of Pulmonary Pathology , 1962, Thorax.
[45] K. Fukuda,et al. Distinct expression patterns of Flk1 and Flt1 in the coronary vascular system during development and after myocardial infarction. , 2018, Biochemical and biophysical research communications.
[46] Lucy Fairclough,et al. Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease , 2009, Respiratory research.
[47] M. Rabinovitch. Molecular pathogenesis of pulmonary arterial hypertension. , 2008, The Journal of clinical investigation.
[48] M. Shibuya,et al. Structure and function of vascular endothelial growth factor receptor-1 and -2. , 1999, Current topics in microbiology and immunology.